Results 271 to 280 of about 698,290 (348)

Have gender and ethnic disparities in ophthalmology disappeared? Insights from a workforce-based study in Israel (2006–2021) [PDF]

open access: gold
Asaf Israeli   +5 more
openalex   +1 more source

Does Modified 5‐Item Frailty Index Correlate With Survival in Oropharyngeal Squamous Cell Carcinoma?

open access: yesHead &Neck, EarlyView.
ABSTRACT Introduction Oropharyngeal squamous cell cancer (OPSCC) is a common subtype of head and neck cancer. It is generally stratified into high, intermediate, and low risk prognostic groups on the basis of HPV (human papillomavirus) status and smoking history (Ang risk stratification).
Marta Chmielecka   +10 more
wiley   +1 more source

Assessment of Agreement in the Diagnosis of Retinopathy of Prematurity between Ophthalmology Residents and Retina Specialists

open access: diamond
Amit Kumar Deb   +6 more
openalex   +1 more source

Nasopharyngeal Endoscopic Resection Extended to the Internal Carotid Artery (Type 4): Technical Notes, Indications, and Outcomes

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Endoscopic surgical approaches for nasopharyngeal malignancies, including recurrent nasopharyngeal carcinoma (rNPC) and nasopharyngeal salivary gland tumors (NSGT), have seen significant development over the last decades. Our groups have expanded the classification of nasopharyngeal endoscopic resections (NER) from type 1 to 3 to ...
Francesco Boaria   +20 more
wiley   +1 more source

Editorial: Reviews in: ophthalmology 2024. [PDF]

open access: yesFront Med (Lausanne)
Panos GD, Deshmukh R.
europepmc   +1 more source

Oncological Impact of Surgical Margin Status After Transoral Laser Microsurgery for Early Glottic Cancer

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Transoral laser microsurgery is a well‐established treatment for early glottic cancer. However, managing patients with close/positive margins remains debated. This study analyzes the relationship between resection margins and oncologic outcomes.
Sae Hatomi   +4 more
wiley   +1 more source

Safety and Efficacy Findings From a Phase Ib/II Study of ASP‐1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

open access: yesHead &Neck, EarlyView.
ABSTRACT Background ASP‐1929 photoimmunotherapy—cetuximab conjugated to IRDye 700DX and red light (690 nm) for localized drug activation—results in rapid, selective cell killing. Methods This phase Ib/II open‐label study evaluated ASP‐1929 photoimmunotherapy plus pembrolizumab in patients with recurrent/metastatic HNSCC (≥ 1 accessible lesion, PD‐L1 ...
David M. Cognetti   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy